We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.1B
AUM Growth
-$646M
Cap. Flow
-$1.62B
Cap. Flow %
-9.46%
Top 10 Hldgs %
3.13%
Holding
5,006
New
607
Increased
1,563
Reduced
1,808
Closed
822

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$62M
2
AMZN icon
Amazon
AMZN
+$53.3M
3
CVS icon
CVS Health
CVS
+$40.3M
4
PYPL icon
PayPal
PYPL
+$34.8M
5
MCD icon
McDonald's
MCD
+$34.2M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$56.8M
2
EXE
Expand Energy Corp
EXE
+$43.4M
3
CHTR icon
Charter Communications
CHTR
+$42.4M
4
CMCSA icon
Comcast
CMCSA
+$40.3M
5
MA icon
Mastercard
MA
+$37.3M

Sector Composition

Rank Sector Weight
1 Financials 12.54%
2 Technology 11.9%
3 Consumer Discretionary 9.76%
4 Healthcare 8.91%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLCO icon
4251
Bausch + Lomb
BLCO
$5.99B
-13,446
Closed -$206K
SRTA
4252
Strata Critical Medical Inc
SRTA
$512M
-58,978
Closed -$238K
BLFS icon
4253
BioLife Solutions
BLFS
$1.7B
-16,992
Closed -$387K
BLNK icon
4254
Blink Charging
BLNK
$87.9M
-12,809
Closed -$227K
BMEA icon
4255
Biomea Fusion
BMEA
$91.3M
-28,493
Closed -$279K
BNR
4256
Burning Rock Biotech
BNR
$92.9M
-2,805
Closed -$67K
BOH icon
4257
Bank of Hawaii
BOH
$3.13B
-19,089
Closed -$1.45M
BOLT icon
4258
Bolt Biotherapeutics
BOLT
$7.78M
-511
Closed -$15K
BPMC
4259
DELISTED
Blueprint Medicines
BPMC
-28,037
Closed -$1.85M
BRDG
4260
DELISTED
Bridge Investment Group
BRDG
-22,909
Closed -$332K
BRFS
4261
DELISTED
BRF SA
BRFS
-41,902
Closed -$98K
BRKL
4262
DELISTED
Brookline Bancorp
BRKL
-246,290
Closed -$2.87M
BRZE icon
4263
Braze
BRZE
$2.99B
-53,408
Closed -$1.86M
BSAC icon
4264
Banco Santander Chile
BSAC
$16.6B
-73,433
Closed -$1.03M
BSBR icon
4265
Santander
BSBR
$43.5B
-56,124
Closed -$317K
BSET icon
4266
Bassett Furniture
BSET
$176M
-13,948
Closed -$219K
BTAI icon
4267
BioXcel Therapeutics
BTAI
$27.8M
-1,988
Closed -$376K
BXC icon
4268
BlueLinx
BXC
$706M
-6,635
Closed -$412K
BBBY
4269
Bed Bath & Beyond
BBBY
$442M
-82,359
Closed -$1.82M
CAE icon
4270
CAE Inc. Common Shares
CAE
$8.74B
-107,293
Closed -$1.65M
CAR icon
4271
PUT
Avis
CAR
$5.02B
-1,800
Closed -$267K
CASH icon
4272
Pathward Financial
CASH
$1.8B
-38,503
Closed -$1.27M
CC icon
4273
Chemours
CC
$2.37B
-280,891
Closed -$6.92M
CCS icon
4274
Century Communities
CCS
$2.03B
-330
Closed -$14K
CCU icon
4275
Compañía de Cervecerías Unidas
CCU
$2.21B
-13,213
Closed -$142K

Similar funds

Cubist Systematic Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Cubist Systematic Strategies held 5,006 positions worth $17.1B, down 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.

Cubist Systematic Strategies withdrew a net $1.62B in Q4 2022, closing 822 positions and reducing 1,808 holdings. Its most notable exit was Edison International, an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb worth $30.8M.

  • Cubist Systematic Strategies's largest Q4 2022 buy was Bristol-Myers Squibb: 428,476 shares worth $30.8M.
  • Cubist Systematic Strategies added most to Apple in Q4 2022, an estimated $62M increase.
  • Cubist Systematic Strategies's biggest Q4 2022 reduction was Visa, cutting an estimated $56.8M.
  • Cubist Systematic Strategies fully exited Edison International in Q4 2022, selling an estimated $25.2M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.1% of its $17.1B portfolio in Q4 2022.
  • Cubist Systematic Strategies opened 607 new positions and closed 822 in Q4 2022.
  • Cubist Systematic Strategies's portfolio value fell 3.6% quarter-over-quarter to $17.1B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.